ELAN

New York Stock Exchange

Elanco Animal Health, Inc. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$9.92B

PE Ratio

—

EV to Ebitda

15.8445

Earnings Yield

-2.08%

Revenue (TTM)

$4.71B

Net Income (TTM)

$-232.0M

Revenue (Annual YoY Growth)

6.22%

Revenue (Quarterly YoY Growth)

12.16%

Profit Margin

-4.92%

Return on Equity

-3.57%

Debt to Equity Ratio

0.6325

Dividend Yield

0.00%

All fundamentals

Core10 fields›

Market Cap$9.92B

Revenue TTM$4.71B

Shares Outstanding499.4M

Float489283012

Float Short4.70%

Days To Cover4.177622772

Short Interest23270871.0

Insider Ownership4.76%

Relative Strength32.3

GARP2535

Growth Estimates17 fields›

Revenue Growth (Annual)6.22%

Revenue Growth (Quarterly YoY)12.16%

Operating Revenue Growth (Annual)0.076468

Operating Revenue Growth (Quarterly YoY)-0.023278

3-Year Revenue Growth2.25%

5-Year Revenue Growth7.57%

EPS Growth (Annual)-168.77%

EPS Growth (Quarterly YoY)-3328.40%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates11.57%

EBITDA Growth (Annual)2.08%

EBITDA Growth (Quarterly YoY)12.21%

CFO Growth (Annual)3.51%

CFO Growth (Quarterly YoY)-38.98%

FCF Growth (Annual)-25.26%

FCF Growth (Quarterly YoY)-62.90%

Operations28 fields›

Revenue TTM$4.71B

Gross Margin TTM43.48%

Gross Margin (Quarterly)39.34%

R&D % of Revenue TTM7.80%

R&D Expenses TTM$368.0M

Operating Margin TTM5.34%

Operating Margin (Quarterly)1.66%

Operating Expenses TTM$1.80B

Profit Margin TTM-4.92%

Profit Margin (Quarterly)-24.13%

Net Income TTM$-232.0M

EPS TTM-0.4663

EPS (Quarterly)-0.5554

EBIT Margin TTM5.34%

EBIT Margin (Quarterly)1.66%

EBITDA Margin TTM19.77%

EBITDA Margin (Quarterly)16.87%

EBITDA TTM$932.0M

CFO % of Revenue TTM11.88%

CFO % of Revenue (Quarterly)9.44%

CFO TTM$560.0M

Cash Margin0.05%

Capex % of Revenue TTM5.85%

Capital Expenditures$276.0M

FCF % of Revenue TTM6.02%

FCF % of Revenue (Quarterly)4.02%

FCF TTM$284.0M

Fundamental Score6

Efficiency6 fields›

ROE-3.57%

ROA-1.75%

ROIC-2.16%

CROCI2.64%

Stock Comp % (Quarterly)1.40%

Stock Comp % TTM1.44%

Valuation16 fields›

P/E Forward21.642

P/S Forward2.2342

P/CFO19.9023

P/FCF39.244

EV/EBITDA (TTM)15.8445

EV/EBITDA Forward15.0992

EV/Revenues (TTM)3.1319

EV/Revenues Forward2.9534

EV/CFO26.5046

EV/FCF (TTM)51.9969

Price To Book1.7063

Price to Tangible Book-2.9511

Earnings Yield-2.08%

FCF Yield2.55%

Dividend Yield0.00%

Value Score1

Relative to Industry5 fields›

Relative Gross Margin (Quarterly)0.7226

Relative P/S1.0448

Relative P/B0.6915

Relative Dividend Yield0

Relative Debt to Equity1.0102

Liquidity15 fields›

Cash Per Share1.0966

Current Ratio2.1653

Cash & ST Assets$545.0M

Total Debt$4.10B

Goodwill & Intangibles$8.19B

Total Assets$13.36B

Total Liabilities$6.81B

Shareholders Equity$6.55B

Debt to Equity0.6325

Debt to Assets31.00%

Interest Expense$289.0M

Times Interest Earned0.872

CFO to Debt (TTM)0.132

Debt to EBITDA (TTM)4.5521

Goodwill % of Assets61.29%

Yields4 fields›

Dividend Yield0.00%

Earnings Yield-2.08%

Buyback Yield0.00%

Shareholder Yield0.38%

Options Flow8 fields›

Call Volume151

Put Volume2350

Put/Call Ratio15.562913907284768

Call $ Volume12982

Put $ Volume177509

Put/Call $ Ratio13.67347095979048

Call OI15265

Put OI11138